Curis Inc CRIS

US Biotechnology
$0.65 β–Ό -6.39% ($-0.04)
⬇️ Below Yest. Low 🔥 High Short Interest 🎈 Low Float 🎢 High Beta
Open $0.64
Prev Close $0.70
Day Range $0.56 – $0.66
52W Range $0.33 – $28.40
Market Cap $4.66M
Beta 3.58
EPS (TTM) $-14.33

πŸ“‹ Company Profile

IndustryBiotechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2000-08-01
Shares Out.4,100,000
Websitecuris.com β†—
Phone16175036500
Employees24
Revenue$0
Gross Profit$0
Net Income-$8.6M
Free Cash Flow-$30.6M
Total Assets$19.0M
Total Liabilities$14.3M
Equity$4.7M
About Curis Inc

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Curis Inc is a publicly traded company under the ticker symbol CRIS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

9 analysts (2026-11-01)

Strong Buy 2
Buy 6
Hold 1

πŸ“° Latest News for CRIS

πŸ‘₯ Related Stocks